Leap Therapeutics Inc. (LPTX)
0.42
-0.04 (-9.35%)
At close: Mar 03, 2025, 3:59 PM
0.42
0.05%
After-hours: Mar 03, 2025, 05:47 PM EST
Leap Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 70.64M | 65.5M | 114.92M | 52.07M | 3.89M | 16.28M | 25.74M | 793K | 20.97M | 10.87M | 19M | 15.32M |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.61M | 35.31M | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 966K | 1.71M | 383K | 1.32M | 1.93M | 1.54M | 1.11M | 2.31M | n/a | 1.25M | 17K | 19K |
| Receivables | 771K | 2.1M | 1.19M | 73K | 185K | 836K | 1.74M | 3.17M | n/a | 379K | 221K | 210K |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30K | n/a | n/a | n/a | n/a |
| Other Current Assets | 183K | 351K | 769K | 130K | 165K | 202K | 177K | 183K | 43K | 157K | 348K | 477K |
| Total Current Assets | 71.6M | 67.95M | 116.87M | 52.27M | 4.24M | 17.32M | 27.66M | 4.03M | 27.92M | 46.72M | 19.56M | 16.01M |
| Property-Plant & Equipment | 262K | 689K | 495K | 593K | 1.15M | 86K | 135K | 119K | 232K | 451K | 330K | 303K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 276K | 827K | 1.38M |
| Total Long-Term Assets | 1.23M | 2.4M | 1.04M | 2.1M | 3.21M | 1.75M | 1.4M | 2.43M | 232K | 1.98M | 1.17M | 1.7M |
| Total Assets | 72.83M | 70.35M | 117.91M | 54.37M | 7.45M | 19.07M | 29.06M | 6.46M | 28.15M | 48.7M | 20.74M | 17.71M |
| Account Payables | 6.46M | 5.66M | 4.19M | 2.72M | 4.57M | 3.58M | 2.62M | 3.23M | 2.05M | 61K | 1.09M | 292K |
| Deferred Revenue | n/a | n/a | n/a | 1.5M | n/a | n/a | n/a | n/a | -3.14M | n/a | n/a | n/a |
| Short-Term Debt | 262K | 832K | 864K | 816K | 948K | n/a | n/a | 30.27M | 3.14M | n/a | n/a | n/a |
| Other Current Liabilities | 5.96M | 4.74M | 4.93M | 2.98M | 2.97M | 2.87M | 3.46M | 2.66M | -3.91M | 2.43M | 876K | 1.21M |
| Total Current Liabilities | 12.68M | 11.22M | 9.99M | 7.37M | 8.49M | 6.45M | 6.08M | 36.16M | 1.28M | 2.49M | 1.97M | 1.5M |
| Long-Term Debt | n/a | 262K | 37K | 144K | 552K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | 204K | 159K | 3.45M | 11.86M | 70.53M | n/a | n/a | n/a | 3.11M |
| Total Long-Term Liabilities | n/a | 262K | 37K | 348K | 711K | 3.45M | 11.86M | 70.53M | n/a | n/a | n/a | 3.11M |
| Total Liabilities | 12.68M | 11.49M | 10.02M | 7.72M | 9.2M | 9.9M | 17.95M | 6.46M | 1.28M | 2.49M | 1.97M | 4.61M |
| Total Debt | 262K | 678K | 469K | 552K | 1.03M | n/a | n/a | 30.27M | 3.14M | n/a | n/a | n/a |
| Common Stock | 26K | 99K | 88K | 60K | 24K | 15K | 12K | n/a | 47K | 45K | 20K | 20K |
| Retained Earnings | -399.58M | -318.17M | -263.57M | -222.99M | -195.17M | -153.53M | -130.4M | -100.67M | -89.3M | -68.2M | -42.75M | -24.42M |
| Comprehensive Income | 106K | 128K | -267K | -579K | 76K | 302K | -268K | 294K | -498K | -533K | 5.12M | 2.48M |
| Shareholders Equity | 60.14M | 58.87M | 107.89M | 46.65M | -1.75M | 9.18M | 11.12M | -100.23M | 26.87M | 46.21M | 18.77M | 13.1M |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.61M | 35.31M | n/a | n/a |